Emiko Sakaida

29PUBLICATIONS
142CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Nov 01, 2026
A multi-center, single-arm, phase 2 trial of dasatinib in T follicular helper cell lymphomas.

|Sep 02, 2026
Epstein-Barr virus-associated chromatin activation and enhancer engagement in T/NK-cell lymphoproliferative diseases.

|Aug 14, 2026
ELTS score and early "warning" define a 2-stage risk framework for failure-free survival in chronic-phase CML.

|Jun 18, 2026
Treatment-free remission and immune profiling after frontline second-generation TKI therapy in CML.

|Jun 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

|Apr 22, 2026
Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

Pageof 5

Frequent Collaborators

9 joint publications

Yoshiko Atsuta

5 joint publications

Chiaki Nakaseko

5 joint publications

Hitoshi Kiyoi

5 joint publications

Noriyoshi Iriyama